To enhance the security of the U.S. drug supply chain, FDA is:

• Preventing and reducing counterfeit and illegal online sales
• Instituting enhanced targeting and screening methods at International Mail Facilities, Express Couriers, and Ports of Entry
• Taking compliance and enforcement actions against unapproved, diverted, or counterfeit drug products